NDC 59353-220 – Retacrit

Epoetin 10000 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC59353-220

Product details

Brand name
Retacrit
Generic name
Epoetin alfa-epbx
Labeler
Vifor (International) Inc.
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA125545
Marketed since
September 11, 2020
Listing expires
December 31, 2026
Pharmacologic class
Erythropoiesis-stimulating Agent

Active ingredients

Uses, dosage, side effects and warnings for Retacrit →

Package NDC codes (1)

Package NDCDescriptionSince
59353-220-1010 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01)Nov 9, 2020

Other Retacrit products